FDA 483 OBSERVATION · #801 OF 1,932 MOST-CITED

Documentation--determination, by whom, date

FDA cited this observation 25 times across 23 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Human Tissue for Transplantation25
BY FISCAL YEAR
FY20261
FY20254
FY20243
FY20231
FY20221
FY20202
FY20192
FY20184
FY20172
FY20165

How FDA worded it — real examples

Documentation of the date of the donor-eligibility determination was not maintained.

Southwest Fertility Center · Phoenix, Arizona · Human Tissue for Transplantation · 2026-04-14

Documentation of the donor-eligibility determination was not maintained.

The Advanced IVF Institute: Charles E. Miller, M.D. & Associates · Naperville, Illinois · Human Tissue for Transplantation · 2025-04-25

Documentation of the donor-eligibility determination and the date of the donor-eligibility determination was not maintained.

Global Premier Fertility Orange County LLC · Newport Beach, California · Human Tissue for Transplantation · 2025-04-11

Documentation of the donor-eligibility determination and the date of the donor-eligibility determination was not maintained.

Fangyinmeng MD Inc. · Irvine, California · Human Tissue for Transplantation · 2025-02-18

Documentation of the donor-eligibility determination, the responsible person who made the donor-eligibility determination and the date of the donor-eligibility determination was not maintained.

InVia Fertility Specialists, PLLC · Hoffman Estates, Illinois · Human Tissue for Transplantation · 2025-02-05

Documentation of the donor-eligibility determination was not maintained.

Community Fertility Specialty Care · Indianapolis, Indiana · Human Tissue for Transplantation · 2024-01-11

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Data integrity (ALCOA+) →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →